Non-accredited investors are estimated to constitute approximately 92% of the U.S. population. Yet restrictive rules governing exempt offerings have significantly limited their freedom to invest in ...

Venus Concept closed a registered direct offering, raising $1.15 million for stock and short-term warrants, intended for corporate purposes. Venus Concept Inc., a leader in medical aesthetic ...

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants TORONTO, June 09, 2025 (GLOBE NEWSWIRE) ...

PHOENIX - Market participants are a bit mystified about what the Municipal Securities Rulemaking Board could be looking for in its upcoming concept release on primary offering practices, although some ...

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its ...

TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into ...

TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and ...

TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering ...

Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, ...